Abstract
The global tuberculosis epidemic is being fuelled by dual infection with human immunodeficiency virus type I. Short-course chemotherapy is effective but usually fails for operational reasons. A community-based treatment programme of twice-weekly fully-supervised treatment is described in which 89% of surviving patients completed treatment under programme conditions. Half the patients were successfully supervised by non-health workers. New approaches are needed to combat the global tuberculosis epidemic.
| Original language | English |
|---|---|
| Pages (from-to) | 647-648 |
| Number of pages | 2 |
| Journal | The Lancet |
| Volume | 343 |
| Issue number | 8898 |
| DOIs | |
| Publication status | Published - 12 Mar 1994 |
| Externally published | Yes |